Dr. Atiq Durrani proved early on in his career that he is a gifted doctor and talented scientist. Dr. Atiq Durrani has developed some of the world’s leading technology and procedures in orthopedic medicine today. Throughout his career, Dr. Atiq Durrani has been recognized by his colleagues and fellow orthopedists for his outstanding contributions to the field of orthopedic medicine. Dr. Atiq Durrani’s advanced education and dedication has furthered his career in orthopedics over the years. Today, Dr. Atiq Durrani continues to research the latest procedures and technologies for the field.
Dr. Atiq Durrani has worked on several research projects throughout his career. Recently, Dr. Atiq Durrani researched the spatial and temporal mapping of the various zones of vertebral growth plate delineating the site and mode of action of various locally produced ligands, their receptors, activated pathways and the genes expressed during longitudinal bone growth in a mouse model. Dr. Atiq Durrani has also worked at identification of the biomechanical and the genetic signal for termination of vertebral growth in a mouse model. Correction of spinal deformity by modulation of vertebral growth through delivery of local growth in a rabbit model has also been a topic researched by Dr. Atiq Durrani.
In addition, Dr. Atiq Durrani has conducted Intervertebral Disc Projects. These projects researched spatial and temporal mapping of the various ligands, their receptors, activated and the genes expressed in the intervertebral disc during physiological aging in mice. Dr. Atiq Durrani also researched the effect of removal of nucleus pulposus cells on the annulus fibrosis in the intervertebral disc, as well as the use of biological growth factors in restoration of intervertebral disc.
Dr. Atiq Durrani has conducted research on Musculoskeletal Oncology related projects as well. These included topics such as expression of vascular markers in aneurismal bone cysts and their correlation to clinical response, and the correlation of gene expression to clinical outcome in various sarcomas using the tumor tissue bank.